Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Neuste KI Analysen zu Mosaic ImmunoEngineering Inc.
Kein Kurs
Schlusskurs OTC 28.04.2026:
0,75 USD
28.04.2026 20:00
Aktuelle Kurse von Mosaic ImmunoEngineering Inc.
Börse
Ticker
Währung
Letzter Umsatz
Kurs
Tagesveränderung
UTC
CPMV
USD
28.04.2026 20:00
0,75 USD
0,42 USD
+127,44 %
Firmenprofil zu Mosaic ImmunoEngineering Inc. Aktie
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
